Arend Jan Winter

Title: Arend Jan Winter: Innovator in Viral Vector Technology

Introduction

Arend Jan Winter, located in Strasbourg, France, is a notable inventor with a focus on innovative biotechnological solutions. He holds a total of three patents that illustrate his significant contributions to the field of virology and gene therapy.

Latest Patents

Among his latest inventions is a patent that concerns chimeric adenoviral vectors. This invention addresses adenoviral vectors designed to include a region essential for heterologous packaging relative to the adenoviral genome from which they originate. The invention also outlines methods for creating a viral preparation that utilizes these adenoviral vectors, as well as the development of a cell and a pharmaceutical composition that incorporates them. Additionally, this patent details their therapeutic or prophylactic applications and discusses an adenoviral genome of animal origin that possesses attenuated packaging properties when compared to its native genome.

Another significant patent by Winter focuses on the expression of a foamy virus envelope protein. This invention includes constructs for the expression of a protein containing at least a modified foamy virus (FV) envelope protein, along with the resultant protein itself. It also presents a complementation cell line that allows for the production of pseudotyped viral particles. The patent further discusses pharmaceutical compositions that include these particles and outlines methods for treating specific diseases.

Career Highlights

Arend Jan Winter continues to work at Transgene S.A., where he contributes his expertise in viral vectors and gene therapy. His work at Transgene reflects a commitment to advancing medical treatments through innovative biotechnology.

Collaborations

He has collaborated with prominent figures in the field, including Axel Rethwilm and Dirk Lindemann. These partnerships enhance his research endeavors and contribute to the broader scientific community by exploring innovative therapeutic solutions.

Conclusion

Arend Jan Winter stands out as a key figure in the realm of viral vector technology, with patents that underscore important advancements in gene therapy. Through his work at Transgene S.A. and collaborations with fellow researchers, Winter continues to pave the way for novel therapeutic approaches that hold promise for treating a variety of diseases.